Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy

To track changes in the V3 env region of HIV-1 quasispecies and determine virus coreceptor use in cell reservoirs of patients on long-term suppressive antiretroviral therapy (ART). Ten patients whose plasma viraemia had been suppressed for a median of 5.5 years were followed for 5 years. The V3 env...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 2014-09, Vol.69 (9), p.2527-2530
Hauptverfasser: Raymond, Stéphanie, Saliou, Adrien, Delobel, Pierre, Cazabat, Michelle, Pasquier, Christophe, Jeanne, Nicolas, Sauné, Karine, Massip, Patrice, Marchou, Bruno, Izopet, Jacques
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2530
container_issue 9
container_start_page 2527
container_title Journal of antimicrobial chemotherapy
container_volume 69
creator Raymond, Stéphanie
Saliou, Adrien
Delobel, Pierre
Cazabat, Michelle
Pasquier, Christophe
Jeanne, Nicolas
Sauné, Karine
Massip, Patrice
Marchou, Bruno
Izopet, Jacques
description To track changes in the V3 env region of HIV-1 quasispecies and determine virus coreceptor use in cell reservoirs of patients on long-term suppressive antiretroviral therapy (ART). Ten patients whose plasma viraemia had been suppressed for a median of 5.5 years were followed for 5 years. The V3 env regions of viruses in peripheral blood mononuclear cells were analysed by ultra-deep sequencing (UDS). HIV-1 tropism was predicted using the geno2pheno 5.75 algorithm and a phenotypic assay. The UDS and phenotypic assay data were concordant for predicting HIV-1 tropism. CXCR4-using viruses detected by UDS accounted for 14.7%-76.5% of the virus populations in samples from five patients at enrolment. Five patients harboured pure R5 virus populations and no X4 viruses emerged during the 5 years. The selection pressures estimated by the dN/dS ratio were acting on the V3 region to produce diversification of the quasispecies in CXCR4-infected patients and purification of the quasispecies in R5-infected patients on effective ART. UDS showed that the virus quasispecies in cell reservoirs of patients on long-term suppressive ART continued to evolve. CXCR4-using variants became more diversified. Analysis of the selection pressures on the virus quasispecies could provide a clearer picture of virus persistence in patients on effective ART.
doi_str_mv 10.1093/jac/dku147
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1553321175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1553321175</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-1c82bf19119a86755ea2fdb689201b9f8445d1a17b5f29803ffec44d6caf73873</originalsourceid><addsrcrecordid>eNpdkUtLBDEQhIMouj4u_gAJeBFh3PQkmcdRRF1B8KJeh0ymg1lnJ2MeK_57Z1n14Kkb-uuiqCLkFNgVsJrPl0rPu_cEotwhMxAFy3JWwy6ZMc5kVgrJD8hhCEvGWCGLap8c5KISrMjljHzerl2fonUDdYYuHl4zoB9JBRtG1BYDVUNHtfOocYzO0xSQ2oFq7HvqMaBfO-vD5ndU0eIQp32gIY3jdA12jZNAtB6jd2vrVU_jG3o1fh2TPaP6gCc_84i83N0-3yyyx6f7h5vrx0xzCTEDXeWtgRqgVlVRSokqN11bVHXOoK1NJYTsQEHZSpPXFePGoBaiK7QyJa9KfkQutrqjdx8JQ2xWNmzcqwFdCg1IyXkOUMoJPf-HLl3yw-RuQwkpipKJibrcUtq7EDyaZvR2pfxXA6zZ1NFMdTTbOib47EcytSvs_tDf_Pk3DyiH4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1554546704</pqid></control><display><type>article</type><title>Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Raymond, Stéphanie ; Saliou, Adrien ; Delobel, Pierre ; Cazabat, Michelle ; Pasquier, Christophe ; Jeanne, Nicolas ; Sauné, Karine ; Massip, Patrice ; Marchou, Bruno ; Izopet, Jacques</creator><creatorcontrib>Raymond, Stéphanie ; Saliou, Adrien ; Delobel, Pierre ; Cazabat, Michelle ; Pasquier, Christophe ; Jeanne, Nicolas ; Sauné, Karine ; Massip, Patrice ; Marchou, Bruno ; Izopet, Jacques</creatorcontrib><description>To track changes in the V3 env region of HIV-1 quasispecies and determine virus coreceptor use in cell reservoirs of patients on long-term suppressive antiretroviral therapy (ART). Ten patients whose plasma viraemia had been suppressed for a median of 5.5 years were followed for 5 years. The V3 env regions of viruses in peripheral blood mononuclear cells were analysed by ultra-deep sequencing (UDS). HIV-1 tropism was predicted using the geno2pheno 5.75 algorithm and a phenotypic assay. The UDS and phenotypic assay data were concordant for predicting HIV-1 tropism. CXCR4-using viruses detected by UDS accounted for 14.7%-76.5% of the virus populations in samples from five patients at enrolment. Five patients harboured pure R5 virus populations and no X4 viruses emerged during the 5 years. The selection pressures estimated by the dN/dS ratio were acting on the V3 region to produce diversification of the quasispecies in CXCR4-infected patients and purification of the quasispecies in R5-infected patients on effective ART. UDS showed that the virus quasispecies in cell reservoirs of patients on long-term suppressive ART continued to evolve. CXCR4-using variants became more diversified. Analysis of the selection pressures on the virus quasispecies could provide a clearer picture of virus persistence in patients on effective ART.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dku147</identifier><identifier>PMID: 24840625</identifier><language>eng</language><publisher>England: Oxford Publishing Limited (England)</publisher><subject>Adult ; Anti-Retroviral Agents - therapeutic use ; Antiretroviral drugs ; Cells ; DNA, Viral - genetics ; env Gene Products, Human Immunodeficiency Virus - genetics ; Evolution ; Female ; Genetic Variation ; Genotype ; Genotype &amp; phenotype ; Genotyping Techniques ; High-Throughput Nucleotide Sequencing ; HIV ; HIV Infections - drug therapy ; HIV Infections - virology ; HIV-1 - classification ; HIV-1 - genetics ; HIV-1 - isolation &amp; purification ; HIV-1 - physiology ; Human immunodeficiency virus ; Humans ; Leukocytes, Mononuclear - virology ; Male ; Middle Aged ; Patients ; Phenotype ; Receptors, HIV - analysis ; Viral Tropism ; Virus Cultivation</subject><ispartof>Journal of antimicrobial chemotherapy, 2014-09, Vol.69 (9), p.2527-2530</ispartof><rights>The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</rights><rights>Copyright Oxford Publishing Limited(England) Sep 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-1c82bf19119a86755ea2fdb689201b9f8445d1a17b5f29803ffec44d6caf73873</citedby><cites>FETCH-LOGICAL-c351t-1c82bf19119a86755ea2fdb689201b9f8445d1a17b5f29803ffec44d6caf73873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24840625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raymond, Stéphanie</creatorcontrib><creatorcontrib>Saliou, Adrien</creatorcontrib><creatorcontrib>Delobel, Pierre</creatorcontrib><creatorcontrib>Cazabat, Michelle</creatorcontrib><creatorcontrib>Pasquier, Christophe</creatorcontrib><creatorcontrib>Jeanne, Nicolas</creatorcontrib><creatorcontrib>Sauné, Karine</creatorcontrib><creatorcontrib>Massip, Patrice</creatorcontrib><creatorcontrib>Marchou, Bruno</creatorcontrib><creatorcontrib>Izopet, Jacques</creatorcontrib><title>Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>To track changes in the V3 env region of HIV-1 quasispecies and determine virus coreceptor use in cell reservoirs of patients on long-term suppressive antiretroviral therapy (ART). Ten patients whose plasma viraemia had been suppressed for a median of 5.5 years were followed for 5 years. The V3 env regions of viruses in peripheral blood mononuclear cells were analysed by ultra-deep sequencing (UDS). HIV-1 tropism was predicted using the geno2pheno 5.75 algorithm and a phenotypic assay. The UDS and phenotypic assay data were concordant for predicting HIV-1 tropism. CXCR4-using viruses detected by UDS accounted for 14.7%-76.5% of the virus populations in samples from five patients at enrolment. Five patients harboured pure R5 virus populations and no X4 viruses emerged during the 5 years. The selection pressures estimated by the dN/dS ratio were acting on the V3 region to produce diversification of the quasispecies in CXCR4-infected patients and purification of the quasispecies in R5-infected patients on effective ART. UDS showed that the virus quasispecies in cell reservoirs of patients on long-term suppressive ART continued to evolve. CXCR4-using variants became more diversified. Analysis of the selection pressures on the virus quasispecies could provide a clearer picture of virus persistence in patients on effective ART.</description><subject>Adult</subject><subject>Anti-Retroviral Agents - therapeutic use</subject><subject>Antiretroviral drugs</subject><subject>Cells</subject><subject>DNA, Viral - genetics</subject><subject>env Gene Products, Human Immunodeficiency Virus - genetics</subject><subject>Evolution</subject><subject>Female</subject><subject>Genetic Variation</subject><subject>Genotype</subject><subject>Genotype &amp; phenotype</subject><subject>Genotyping Techniques</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - classification</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - isolation &amp; purification</subject><subject>HIV-1 - physiology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Leukocytes, Mononuclear - virology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Phenotype</subject><subject>Receptors, HIV - analysis</subject><subject>Viral Tropism</subject><subject>Virus Cultivation</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLBDEQhIMouj4u_gAJeBFh3PQkmcdRRF1B8KJeh0ymg1lnJ2MeK_57Z1n14Kkb-uuiqCLkFNgVsJrPl0rPu_cEotwhMxAFy3JWwy6ZMc5kVgrJD8hhCEvGWCGLap8c5KISrMjljHzerl2fonUDdYYuHl4zoB9JBRtG1BYDVUNHtfOocYzO0xSQ2oFq7HvqMaBfO-vD5ndU0eIQp32gIY3jdA12jZNAtB6jd2vrVU_jG3o1fh2TPaP6gCc_84i83N0-3yyyx6f7h5vrx0xzCTEDXeWtgRqgVlVRSokqN11bVHXOoK1NJYTsQEHZSpPXFePGoBaiK7QyJa9KfkQutrqjdx8JQ2xWNmzcqwFdCg1IyXkOUMoJPf-HLl3yw-RuQwkpipKJibrcUtq7EDyaZvR2pfxXA6zZ1NFMdTTbOib47EcytSvs_tDf_Pk3DyiH4w</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Raymond, Stéphanie</creator><creator>Saliou, Adrien</creator><creator>Delobel, Pierre</creator><creator>Cazabat, Michelle</creator><creator>Pasquier, Christophe</creator><creator>Jeanne, Nicolas</creator><creator>Sauné, Karine</creator><creator>Massip, Patrice</creator><creator>Marchou, Bruno</creator><creator>Izopet, Jacques</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20140901</creationdate><title>Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy</title><author>Raymond, Stéphanie ; Saliou, Adrien ; Delobel, Pierre ; Cazabat, Michelle ; Pasquier, Christophe ; Jeanne, Nicolas ; Sauné, Karine ; Massip, Patrice ; Marchou, Bruno ; Izopet, Jacques</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-1c82bf19119a86755ea2fdb689201b9f8445d1a17b5f29803ffec44d6caf73873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Anti-Retroviral Agents - therapeutic use</topic><topic>Antiretroviral drugs</topic><topic>Cells</topic><topic>DNA, Viral - genetics</topic><topic>env Gene Products, Human Immunodeficiency Virus - genetics</topic><topic>Evolution</topic><topic>Female</topic><topic>Genetic Variation</topic><topic>Genotype</topic><topic>Genotype &amp; phenotype</topic><topic>Genotyping Techniques</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - classification</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - isolation &amp; purification</topic><topic>HIV-1 - physiology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Leukocytes, Mononuclear - virology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Phenotype</topic><topic>Receptors, HIV - analysis</topic><topic>Viral Tropism</topic><topic>Virus Cultivation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raymond, Stéphanie</creatorcontrib><creatorcontrib>Saliou, Adrien</creatorcontrib><creatorcontrib>Delobel, Pierre</creatorcontrib><creatorcontrib>Cazabat, Michelle</creatorcontrib><creatorcontrib>Pasquier, Christophe</creatorcontrib><creatorcontrib>Jeanne, Nicolas</creatorcontrib><creatorcontrib>Sauné, Karine</creatorcontrib><creatorcontrib>Massip, Patrice</creatorcontrib><creatorcontrib>Marchou, Bruno</creatorcontrib><creatorcontrib>Izopet, Jacques</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raymond, Stéphanie</au><au>Saliou, Adrien</au><au>Delobel, Pierre</au><au>Cazabat, Michelle</au><au>Pasquier, Christophe</au><au>Jeanne, Nicolas</au><au>Sauné, Karine</au><au>Massip, Patrice</au><au>Marchou, Bruno</au><au>Izopet, Jacques</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>69</volume><issue>9</issue><spage>2527</spage><epage>2530</epage><pages>2527-2530</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>To track changes in the V3 env region of HIV-1 quasispecies and determine virus coreceptor use in cell reservoirs of patients on long-term suppressive antiretroviral therapy (ART). Ten patients whose plasma viraemia had been suppressed for a median of 5.5 years were followed for 5 years. The V3 env regions of viruses in peripheral blood mononuclear cells were analysed by ultra-deep sequencing (UDS). HIV-1 tropism was predicted using the geno2pheno 5.75 algorithm and a phenotypic assay. The UDS and phenotypic assay data were concordant for predicting HIV-1 tropism. CXCR4-using viruses detected by UDS accounted for 14.7%-76.5% of the virus populations in samples from five patients at enrolment. Five patients harboured pure R5 virus populations and no X4 viruses emerged during the 5 years. The selection pressures estimated by the dN/dS ratio were acting on the V3 region to produce diversification of the quasispecies in CXCR4-infected patients and purification of the quasispecies in R5-infected patients on effective ART. UDS showed that the virus quasispecies in cell reservoirs of patients on long-term suppressive ART continued to evolve. CXCR4-using variants became more diversified. Analysis of the selection pressures on the virus quasispecies could provide a clearer picture of virus persistence in patients on effective ART.</abstract><cop>England</cop><pub>Oxford Publishing Limited (England)</pub><pmid>24840625</pmid><doi>10.1093/jac/dku147</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2014-09, Vol.69 (9), p.2527-2530
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_1553321175
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Adult
Anti-Retroviral Agents - therapeutic use
Antiretroviral drugs
Cells
DNA, Viral - genetics
env Gene Products, Human Immunodeficiency Virus - genetics
Evolution
Female
Genetic Variation
Genotype
Genotype & phenotype
Genotyping Techniques
High-Throughput Nucleotide Sequencing
HIV
HIV Infections - drug therapy
HIV Infections - virology
HIV-1 - classification
HIV-1 - genetics
HIV-1 - isolation & purification
HIV-1 - physiology
Human immunodeficiency virus
Humans
Leukocytes, Mononuclear - virology
Male
Middle Aged
Patients
Phenotype
Receptors, HIV - analysis
Viral Tropism
Virus Cultivation
title Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A06%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20HIV-1%20quasispecies%20and%20coreceptor%20use%20in%20cell%20reservoirs%20of%20patients%20on%20suppressive%20antiretroviral%20therapy&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Raymond,%20St%C3%A9phanie&rft.date=2014-09-01&rft.volume=69&rft.issue=9&rft.spage=2527&rft.epage=2530&rft.pages=2527-2530&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dku147&rft_dat=%3Cproquest_cross%3E1553321175%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1554546704&rft_id=info:pmid/24840625&rfr_iscdi=true